TEST
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announced…...
February 16, 2021
FLUROTECH ADDS LIFE SCIENCES EXPERT DR. TIMOTHY J. HOLZER TO SCIENTIFIC ADVISORY BOARD
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announced that accomplished…...
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of COVID-19 and other pathogens, today announced that Brian…...
February 3, 2021
FluroTech Provides Executive Update on Program Advancements
FluroTech Ltd (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a lead ing developer of spectroscopy-based technology, together with FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of COVID-19 and other pathogens, today announced that…...
January 25, 2021
FLUROTECH EXPANDS NANOCOMPOSIX MANDATE; INITIATING COVID-19 TEST PERFORMANCE EVALUATION AND VALIDATION
FluroTech Ltd. (TSXV: TEST ) (OTCQB: FLURF ) (“FluroTech” or the “Company”), is pleased to announce that, FluroTest Ltd. (“FluroTest”) has retained San Diego-based nanoComposix, a leading life sciences nanotechnology company that specializes in R&D and manufacturing of lateral flow…...
Calgary, Alberta, January 21, 2021 – FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement (the Offering”). 15,644,844 Units…...
January 14, 2021
FluroTech Announces Appointment of Regulatory Consultant
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce it has retained PandiaDx LLC (“PandiaDX”) for regulatory guidance and services in preparation of its regulatory submissions to the U.S. Food and Drug Administration.Melina Cimler, Ph.D.…...
December 2, 2020
FluroTech Announces Product Solution to Safely Open Universities, Colleges, as Well as Primary and Secondary Schools
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest Systems Ltd. (“FluroTest”) will launch its first product solution to provide universities, colleges, as well as primary and secondary schools and their communities with…...
November 19, 2020
FluroTech Announces Its Safe Air Travel Product Solution
FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product solution aimed at solving the testing problems airlines and airport terminal operators face as they work to make air…...